Clinical Trials on Metastatic Esophageal Cancer in Germany
Total 2753 results
-
German Breast GroupCompletedBreast Cancer MetastaticGermany
-
iOMEDICO AGRoche Pharma AG; Arbeitsgemeinschaft fur Internistische Onkologie; Arbeitskreis...CompletedMetastatic Breast CancerGermany
-
NovartisCompletedMetastatic Breast CancerGermany
-
Prof. Wolfgang JanniRoche Pharma AG; Novartis Pharmaceuticals; Celgene Corporation; Eisai GmbHActive, not recruiting
-
University Hospital TuebingenPaul Ehrlich Institute, Langen, GermanyCompletedMetastatic Breast CancerGermany
-
Prof. Wolfgang JanniCompletedHER2-negative and Hormone-receptor Positive Metastatic Breast Cancer | HER2-negative Circulating Tumor Cells | Postmenopausal Female PatientsGermany
-
Hoffmann-La RocheTerminatedAdvanced/Metastatic Head and Neck, Oesophageal and Cervical CancersKorea, Republic of, France, Spain, Belgium, United Kingdom, Singapore, Israel, Russian Federation, Taiwan, Switzerland, Turkey, United States, New Zealand, Poland, Germany
-
Academisch Medisch Centrum - Universiteit van Amsterdam...RecruitingEsophageal Neoplasms | Lymph Node MetastasesNetherlands, United States, Italy, Spain, Sweden, Brazil, Canada, China, Finland, Germany, Greece, Hong Kong, India, Japan
-
Ludwig-Maximilians - University of MunichCompletedMetastatic Renal CancerGermany
-
German Breast GroupTerminatedMetastatic Breast CancerGermany
-
Technical University of MunichEli Lilly and CompanyRecruitingBreast Cancer/ Metastatic Breast CancerGermany
-
AIO-Studien-gGmbHNovartis Pharmaceuticals; iOMEDICO AGCompletedHer2-negative Metastatic Breast Cancer | Her2-negative Locally Advanced Breast CancerGermany
-
German Breast GroupCompletedMetastatic Breast CancerGermany
-
WiSP Wissenschaftlicher Service Pharma GmbHBristol-Myers Squibb; Roche Pharma AGCompleted
-
Heinrich-Heine University, DuesseldorfUniversity Hospital of CologneRecruitingCancer of Esophagus | Esophagogastric Junction DisorderGermany
-
BioInvent International ABActive, not recruitingHER2-positive Breast Cancer | HER2-positive Gastric Cancer | Metastatic Gastric Adenocarcinoma | Metastatic Gastroesophageal Junction Adenocarcinoma | HER2-positive Metastatic Breast CancerSpain, United Kingdom, Germany
-
Universitätsklinikum Hamburg-EppendorfCompleted
-
Heidelberg UniversityCompletedEsophageal Cancer | Anastomotic LeakageGermany
-
Claudia Lorenz-SchlüterTerminatedMetastatic Breast CancerGermany
-
Universitätsklinikum Hamburg-EppendorfCompleted
-
Novartis PharmaceuticalsRoche - Prof. Dr. Jens Huober et al.TerminatedMetastatic Breast CancerGermany
-
Heidelberg UniversityDafra Pharma; Hector-Stiftung; Monika-Kutzner Stiftung, Berlin, Germany; HEIFAN-Heidelberger...CompletedMetastatic Breast Cancer | Locally Advanced Breast CancerGermany
-
Klinikum Garmisch-PatenkirchenNot yet recruitingReflux, Gastroesophageal | Gastro-esophageal RefluxGermany
-
German Breast GroupPfizer; AMS Advanced Medical Services GmbHRecruitingMetastatic Breast CancerGermany
-
Gesellschaft fur Medizinische Innovation - Hamatologie...iOMEDICO AGCompletedMetastatic Breast CancerGermany
-
University of Erlangen-Nürnberg Medical SchoolUnknownCancer, Lung | Cancer of EsophagusGermany
-
Taiho Oncology, Inc.TerminatedMetastatic Diffuse Gastric Cancer Including Carcinoma of the Gastro-esophageal JunctionBelgium, Spain, United States, Italy, Estonia, Russian Federation, Bulgaria, Hungary, Croatia, Israel, Mexico, Poland, Portugal, Romania, South Africa, Ukraine, United Kingdom, Brazil, Germany, Argentina
-
AIO-Studien-gGmbHCelgeneTerminatedMetastatic Pancreatic Ductal AdenocarcinomaGermany
-
AO Innovation Translation CenterAO Foundation, AO SpineRecruitingMetastatic Spine TumorUnited States, Canada, Hungary, Australia, Germany, Italy, Japan, Netherlands, Singapore, Switzerland
-
AIO-Studien-gGmbHBristol-Myers Squibb; Eli Lilly and Company; Merck Sharp & Dohme LLC; Pfizer; Gilead... and other collaboratorsRecruitingSmall-cell Lung Cancer | Non-small Cell Lung Cancer Metastatic | Non-small Cell Lung Cancer Stage I | Metastatic Non-small Cell Lung Cancer (NSCLC) | Non Small Cell Lung Cancer Stage III | Non-small Cell Lung Cancer Stage IIGermany
-
German Breast GroupNovartisTerminatedMetastatic Breast CancerGermany
-
iOMEDICO AGCompleted
-
German Cancer Research CenterUniversity Hospital HeidelbergRecruitingMetastatic Breast CancerGermany
-
NovartisTerminatedBreast Cancer With Bone MetastasisGermany
-
AIO-Studien-gGmbHCompleted
-
Institut fuer FrauengesundheitEisai GmbHRecruitingAssessing ImmunoResponse Post Eribulin: Eribulin and Immunogenicity in Advanced Breast Cancer (AIRE)Breast Cancer Female | Breast Cancer Metastatic | Neoplasm, BreastGermany
-
Asklepios Kliniken Hamburg GmbHCompletedColon Cancer Liver Metastasis | Contrast Enhances Intraoperative Ultrasound | Imaging for Liver Cancer | Imaging for Liver MetastasisGermany
-
Merus N.V.RecruitingGastric Cancer | Head and Neck Squamous Cell Carcinoma | Esophageal Squamous Cell Carcinoma | Non-Small Cell Lung Cancer MetastaticUnited States, Spain, France, Italy, Netherlands, Belgium, Korea, Republic of, Germany, Singapore
-
University of AarhusCentre Leon Berard; University College London Hospitals; Aarhus University Hospital and other collaboratorsRecruitingEsophageal Cancer | Radiotherapy | Proton Therapy | Side EffectUnited Kingdom, France, Belgium, Denmark, Germany, Italy, Netherlands, Switzerland
-
University of CologneNot yet recruitingGastric Cancer | Colorectal Cancer | Oesophageal Cancer | Duodenal CancerGermany
-
Heidelberg UniversityVerein für Krebsforschung, Arlesheim, Swizzerland; Weleda AG, D-73525 Schwäbisch...CompletedMetastatic Breast CancerGermany
-
AVEO Pharmaceuticals, Inc.CompletedMetastatic Breast CancerUnited States, Germany
-
AIO-Studien-gGmbHBayer; Institut für Klinisch-Onkologische Forschung (IKF) am Krankenhaus Nordwest...CompletedPretreated Metastatic Colorectal CancerGermany
-
Technical University of MunichNovartisTerminated
-
Dominik Paul ModestRecruitingMetastatic Colorectal CancerGermany
-
Ludwig-Maximilians - University of MunichActive, not recruitingMetastatic Colorectal CancerGermany
-
Ludwig-Maximilians - University of MunichActive, not recruitingFOLFOXIRI Plus Cetuximab vs. FOLFOXIRI Plus Bevacizumab 1st-line in BRAF-mutated mCRC (AIO-KRK-0116)Metastatic Colorectal CancerGermany
-
Servier Deutschland GmbHiOMEDICO AGCompleted
-
Novartis PharmaceuticalsCompletedPain | Cancer | Neoplasm MetastasisGermany
-
Krankenhaus NordwestCompletedGastric Cancer | Adenocarcinoma of the Esophagogastric JunctionGermany